Related Experiment Video
Updated: Jun 21, 2026
Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
Published on: November 29, 2013
Screening for essential fatty acid deficiency in at risk infants
1clbrpav@bigpond.net.au
Insights
Screening for essential fatty acid deficiency (EFAD) in at-risk infants shows promise for early detection and prevention. Further trials are needed to confirm cost-benefits before widespread implementation.
Area of Science:
- Nutritional Science
- Pediatric Health
- Preventative Medicine
Background:
- Essential fatty acids (EFAs) are crucial for infant development, including brain and visual maturation.
- Essential fatty acid deficiency (EFAD) results from insufficient omega-3 or omega-6 intake.
- Early detection and intervention are vital for optimal infant health outcomes.
Purpose of the Study:
- To evaluate the potential benefits and efficacy of screening at-risk infants for EFAD.
- To assess the suitability of an EFAD screening program based on UK National Screening Committee criteria.
- To determine if implementing a screening program is a beneficial preventative clinical measure.
Main Methods:
- Analysis of an EFAD screening program against established UK National Screening Committee criteria.
- Review of existing literature on the benefits of treating fatty acid deficiencies.
- Proposal for a trial screening program to assess cost-benefits.
Main Results:
- The proposed EFAD screening program aligns with several UK National Screening Committee criteria, including condition assessment and screening test acceptance.
- Evidence suggests benefits in treating existing fatty acid deficiencies.
- Further research is required to fully establish the advantages and feasibility of a screening program.
Conclusions:
- Screening for EFAD in at-risk infants meets key criteria for a public health screening program.
- While treatment benefits are noted, more investigation is needed before program establishment.
- A trial screening program is recommended to thoroughly analyze cost-effectiveness.
Abstract:
Essential fatty acids are critical during the initial years of infancy and are necessary for brain development, visual maturity, and cardiovascular health. Essential fatty acid deficiency (EFAD) develops where there is inadequate status of omega-3 or omega-6 fatty acids. This paper raises the idea and question of whether screening for EFAD in at risk infants is beneficial and assesses the efficacy of introducing this as a preventative clinical measure. The introduction of the screening program is analysed against the criteria outlined by the UK National Screening Committee. Screening to detect EFAD in at risk infants satisfies many of the criteria proposed by the UK screening committee, including condition assessed, accepted screening tests, and screening program fundamentals. While a range of benefits are reported in the treatment of fatty acid deficiencies, several areas require further investigation prior to establishment. Hence, a trial screening program is proposed to more fully analyse the cost-benefits.
More Related Videos
Related Concept Videos
01:18Lipids: Dietary Sources and Requirements
01:28Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...